Artiforte0.25%

Artiforte is a mineral salt supplement used for the following indications:

Established / Guideline-Supported Uses

• Treatment and prevention of zinc deficiency — dietary or condition-related zinc deficiency, including malabsorption syndromes, chronic diarrhea, malnutrition, and certain gastrointestinal or liver diseases.
• Adjunct management of acute diarrhea in children — recommended by the World Health Organization (WHO) alongside oral rehydration therapy (ORT) to reduce the duration and severity of the current diarrheal episode and lower the risk of recurrence over the following 2-3 months. Artiforte is not a substitute for oral rehydration therapy and is used only as an adjunct to it.

General / Supplemental Use

• General nutritional supplementation in individuals with inadequate dietary zinc intake or increased physiological requirements (e.g., pregnancy), as directed by a physician or per approved dietary supplement labeling.

Each formulation of Zinc Sulfate provides a specified amount of elemental zinc, depending on the salt hydrate form (monohydrate or heptahydrate) and dosage form (tablet, dispersible tablet, syrup, or injectable solution). The elemental zinc content of a given strength of Zinc Sulfate should always be confirmed on the product label, since different hydrate forms yield different amounts of elemental zinc per unit weight.

Artiforte is an inorganic mineral salt used as a source of supplemental zinc, an essential trace element. Zinc functions as a cofactor for more than 300 enzymes involved in protein synthesis, DNA synthesis, immune function, wound healing, cell division, and normal growth and development. Artiforte is available in oral tablet, dispersible tablet, syrup/suspension, and injectable (parenteral trace element additive) forms, and is used both as a general nutritional supplement and, in pediatric populations, as a WHO-recommended adjunct in the management of acute diarrhea.

Artiforte belongs to the therapeutic class of Minerals and Trace Element Supplements.

Zinc Sulfate provides elemental zinc, which is absorbed primarily in the duodenum and jejunum through both carrier-mediated and passive diffusion processes. Zinc absorption is inversely related to the amount ingested and is reduced by dietary phytates and by concurrent high intake of calcium or iron.

Absorbed zinc circulates bound to albumin and other plasma proteins, is taken up by the liver, and is distributed to tissues, where it acts as a structural and catalytic cofactor for numerous metalloenzymes (e.g., carbonic anhydrase, alkaline phosphatase, RNA/DNA polymerases, superoxide dismutase). Zinc supports normal immune cell function, epithelial integrity and wound healing, taste and smell perception, and growth. In diarrheal illness, zinc from Zinc Sulfate is thought to promote enterocyte regeneration and mucosal immune function, underlying its role in shortening the duration and severity of acute diarrhea in children. Zinc is eliminated mainly in the feces (unabsorbed dietary zinc plus endogenous secretions), with smaller amounts lost in urine and sweat.

Artiforte may be taken orally as a tablet, dispersible tablet, or syrup. Dispersible tablets can be dissolved in a small amount of clean drinking water or breast milk for infants and young children. Give Artiforte on an empty stomach when possible for best absorption; if stomach upset occurs, it can be taken with a small amount of food instead. Doses of iron, calcium, or certain antibiotics (see Interactions) should be separated from Artiforte by at least 2 hours. Injectable forms of Artiforte, used as a trace element additive in parenteral nutrition, must be administered only by a healthcare professional in a clinical setting.

Artiforte has the following clinically significant interactions:

• Tetracycline and fluoroquinolone antibiotics (e.g., doxycycline, ciprofloxacin): Artiforte can chelate these antibiotics in the gut, reducing their absorption and effectiveness. Separate dosing by at least 2 hours (antibiotic before zinc) up to 4-6 hours apart where possible.
• Penicillamine: zinc from Artiforte can reduce penicillamine absorption and effectiveness; separate dosing.
• Iron and copper supplements: concurrent high-dose Artiforte can reduce absorption of iron and copper; separate dosing and monitor with prolonged co-administration.
• Calcium and phosphorus-containing products: may reduce absorption of zinc from Artiforte when taken concurrently in high amounts.
• Thiazide diuretics: may increase urinary zinc excretion, potentially increasing zinc requirements with long-term use of Artiforte.

Common side effects of Artiforte include:

• Nausea, vomiting, gastric irritation, and abdominal cramps (more common on an empty stomach or at higher doses)
• Diarrhea or constipation
• Metallic or unpleasant taste
• Headache

Less common, and generally associated with prolonged high-dose use: copper deficiency (which may cause sideroblastic anemia and neurological effects), reduced HDL cholesterol, and paradoxically impaired immune function with excessive intake. See Precautions and Warnings and Overdose Effects for further detail.

Artiforte at standard recommended dietary/supplemental doses is generally considered acceptable during pregnancy and lactation and is often included as part of prenatal nutritional supplementation. However, Artiforte should be used only as directed by a physician, at doses appropriate for pregnancy or lactation, since zinc intake above recommended levels may interfere with copper and iron status. Use Artiforte only if clearly needed and as directed; consult a physician before use during pregnancy or breastfeeding, particularly for doses above standard nutritional supplementation.

Use Artiforte with the following precautions:

• Take with a small amount of food if gastric irritation occurs, understanding this may modestly reduce absorption.
• Prolonged use of high-dose Artiforte without adequate copper intake can cause copper deficiency, associated anemia, neutropenia, and neurological symptoms; long-term high-dose use should be under medical supervision, with periodic monitoring of copper status if prolonged.
• Artiforte is not a substitute for oral rehydration therapy (ORT) in acute diarrheal illness; it is used only as an adjunct alongside appropriate fluid and electrolyte replacement.
• Separate dosing of Artiforte from certain antibiotics and minerals as described under Interactions to avoid reduced absorption or effectiveness.
• Use with caution in patients with renal impairment, in whom zinc excretion may be reduced.

Acute overdose of Artiforte may cause nausea, vomiting, abdominal pain, diarrhea, headache, and, with very high doses, gastric erosion or renal impairment. Chronic excessive intake of Artiforte can cause copper deficiency, sideroblastic anemia, neutropenia, and neurological effects. If overdose of Artiforte is suspected, seek immediate medical attention or contact a poison control center; do not attempt home treatment. Management is generally supportive (discontinuation of zinc, supportive care, and correction of copper deficiency if present) and should be directed by a healthcare professional.

Store Artiforte at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Renal impairment: use Artiforte with caution; reduced renal excretion of zinc may increase the risk of accumulation with prolonged high-dose use.

Hepatic impairment: no specific dose adjustment of Artiforte is well established; use as clinically indicated.

Elderly: no specific dose adjustment of Artiforte is generally required; use per nutritional need, with monitoring of copper status during prolonged high-dose use.

See Pediatric Uses and Pregnancy and Lactation above for further population-specific guidance on Artiforte.

For acute diarrhea, Artiforte is typically given for 10-14 days per WHO guidance, even after diarrhea resolves, to replenish zinc losses and reduce the risk of recurrence. For treatment of diagnosed zinc deficiency, the duration of Artiforte is individualized based on clinical and/or laboratory response, as directed by a physician. For general nutritional supplementation, duration follows product labeling or physician recommendation.

Nutritional Supplements > Minerals and Trace Elements > Zinc Salts (Zinc Sulfate)

Zinc Sulfate dissociates in solution to release zinc ions, which are absorbed and act as an essential cofactor in more than 300 metalloenzymes governing DNA/RNA synthesis, protein synthesis, and cell division. Zinc released from Zinc Sulfate stabilizes cell membranes, supports T-lymphocyte and neutrophil function important for immune defense, promotes epithelial proliferation relevant to wound healing and intestinal mucosal repair, and is required for normal taste bud and olfactory function. These combined actions underlie the role of Zinc Sulfate in correcting deficiency states and in reducing the duration of acute diarrheal illness in children.

Artiforte is well established for use in children as an adjunct in the management of acute diarrhea, per WHO/UNICEF guidance: 10 mg/day elemental zinc for infants under 6 months, or 20 mg/day for children 6 months to 5 years, for 10-14 days, given alongside oral rehydration therapy. Artiforte is also used for treatment of diagnosed zinc deficiency in children, with dosing individualized by age, weight, and severity under medical supervision. Dispersible tablet or syrup formulations of Artiforte are preferred for accurate pediatric dosing where available. Safety and efficacy of specific formulations or doses of Artiforte outside these established uses have not been established in children; use only as directed by a pediatrician.